Dermata Therapeutics (DRMA) Short term Debt (2020)
Dermata Therapeutics (DRMA) posted quarterly Short term Debt of $556160.0 for Q4 2020.
Dermata Therapeutics (DRMA) Short term Debt (2020) Analysis & Trends
Dermata Therapeutics' Short term Debt history runs 1 years deep, the most recent figure standing at $556160.0 for Q4 2020.
- In Q4 2020, Short term Debt changed N/A year-over-year to $556160.0; the TTM figure through Dec 2020 stood at $556160.0 (changed N/A YoY), while the FY2020 annual figure was $556160.0, changed N/A from the prior year.
- Short term Debt for Q4 2020 stood at $556160.0.
- The five-year high for Short term Debt was $556160.0 in Q4 2020, with the low at $556160.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.41 Bn | 131.56 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.14 Bn | 78.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.52 Bn | 60.34 Bn | 1.37 Bn |
| 4 | Moderna | 58.21 Bn | 53.07 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Dermata Therapeutics | 5.38 Mn | 5.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 556,160.00 |